Sort   by:  
 Page size 
UnknownThe histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2).
Not available
S-EPMC6195192 | biostudies-literature
UnknownWorldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2).
Not available
S-EPMC6195190 | biostudies-literature
UnknownGlobal surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).
Not available
S-EPMC4588097 | biostudies-literature
UnknownEvaluation of individual and ensemble probabilistic forecasts of COVID-19 mortality in the United States.
Not available
S-EPMC9169655 | biostudies-literature
UnknownInternational Consensus for the Dosing of Corticosteroids in Childhood-Onset Systemic Lupus Erythematosus With Proliferative Lupus Nephritis.
Not available
S-EPMC8766607 | biostudies-literature
UnknownThe Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics.
Not available
S-EPMC5804835 | biostudies-literature
UnknownEffect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis.
Not available
S-EPMC8078131 | biostudies-literature
UnknownEfficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Not available
S-EPMC5731244 | biostudies-literature
UnknownSafety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.
Not available
S-EPMC11249957 | biostudies-literature
UnknownApolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Not available
S-EPMC9422774 | biostudies-literature
Sort   by:  
 Page size